首页 > 最新文献

Turkish Thoracic Journal最新文献

英文 中文
Co-infection of COVID-19 and Tuberculosis. COVID-19 和结核病的合并感染。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2022-01-01 DOI: 10.5152/TurkThoracJ.2022.21045
Lütfiye Kılıç, Sedat Altın, Mediha Gönenç Ortaköylü, Zehra Dilek Kanmaz, Tayjen Tutar, Gülcihan Zehra Özkan

Objective: Tuberculosis and COVID-19 diseases occur more frequently in people with similar risk factors. This study aimed to share the data on active tuberculosis patients during the severe acute respiratory syndrome coronavirus 2 pandemic.

Material and methods: The registration information of TB outpatient clinic between November 1, 2019, and April 20, 2020, was screened. A 7-question survey was administered to the patients who were diagnosed with active tuberculosis and who were agreed to participate in the study.

Results: A total of 309 patients with active tuberculosis were evaluated, the average age of the patients was 42.5 ± 18.5 years, and 70% were male. The percentage of having at least 1 comorbidity was 30.4%. The percentage of coronavirus disease 2019 disease in our study population was 1.9%; none of the patients of coronavirus disease 2019 were taken into the intensive care unit or dead due to clinical deterioration and/or respiratory failure. On the other hand, in this process it was announced that 146 457 cases were diagnosed with coronavirus disease 2019 throughout the country, of which 72% had inpatient treatment, 2% died, and 944 patients were still being treated in the intensive care unit, of which 490 were intubated. The positivity ratio of the reverse transcription-polymerase chain reaction test was 20.0% in the study group, while 20.3% in the İstanbul population.

Conclusion: Tuberculosis patients might be more disadvantageous than the normal population in terms of the risk of exposure to severe acute respiratory syndrome coronavirus 2, but this does not cause an increase in the frequency and severity of coronavirus disease 2019 disease in active tuberculosis patients.

目的:肺结核和COVID-19疾病多发于具有相似危险因素的人群。本研究旨在分享严重急性呼吸系统综合征冠状病毒2大流行期间活动性肺结核患者的数据:筛选了2019年11月1日至2020年4月20日期间结核病门诊的登记信息。对确诊为活动性肺结核并同意参与研究的患者进行了 7 个问题的调查:共评估了 309 名活动性肺结核患者,患者平均年龄为(42.5±18.5)岁,70%为男性。至少患有一种合并症的比例为 30.4%。在我们的研究人群中,冠状病毒病2019年最新注册送彩金的比例为1.9%;冠状病毒病2019年最新注册送彩金的患者均未因临床病情恶化和/或呼吸衰竭而被送入重症监护室或死亡。另一方面,在这一过程中,据公布,全国共确诊冠状病毒病2019年病例146 457例,其中72%接受了住院治疗,2%死亡,944名患者仍在重症监护室接受治疗,其中490人插管。研究组的反转录聚合酶链反应检测阳性率为20.0%,而伊斯坦布尔人群的阳性率为20.3%:肺结核患者在接触严重急性呼吸系统综合征冠状病毒 2 的风险方面可能比正常人群更为不利,但这并不会导致活动性肺结核患者 2019 年冠状病毒病的发病频率和严重程度增加。
{"title":"Co-infection of COVID-19 and Tuberculosis.","authors":"Lütfiye Kılıç, Sedat Altın, Mediha Gönenç Ortaköylü, Zehra Dilek Kanmaz, Tayjen Tutar, Gülcihan Zehra Özkan","doi":"10.5152/TurkThoracJ.2022.21045","DOIUrl":"10.5152/TurkThoracJ.2022.21045","url":null,"abstract":"<p><strong>Objective: </strong>Tuberculosis and COVID-19 diseases occur more frequently in people with similar risk factors. This study aimed to share the data on active tuberculosis patients during the severe acute respiratory syndrome coronavirus 2 pandemic.</p><p><strong>Material and methods: </strong>The registration information of TB outpatient clinic between November 1, 2019, and April 20, 2020, was screened. A 7-question survey was administered to the patients who were diagnosed with active tuberculosis and who were agreed to participate in the study.</p><p><strong>Results: </strong>A total of 309 patients with active tuberculosis were evaluated, the average age of the patients was 42.5 ± 18.5 years, and 70% were male. The percentage of having at least 1 comorbidity was 30.4%. The percentage of coronavirus disease 2019 disease in our study population was 1.9%; none of the patients of coronavirus disease 2019 were taken into the intensive care unit or dead due to clinical deterioration and/or respiratory failure. On the other hand, in this process it was announced that 146 457 cases were diagnosed with coronavirus disease 2019 throughout the country, of which 72% had inpatient treatment, 2% died, and 944 patients were still being treated in the intensive care unit, of which 490 were intubated. The positivity ratio of the reverse transcription-polymerase chain reaction test was 20.0% in the study group, while 20.3% in the İstanbul population.</p><p><strong>Conclusion: </strong>Tuberculosis patients might be more disadvantageous than the normal population in terms of the risk of exposure to severe acute respiratory syndrome coronavirus 2, but this does not cause an increase in the frequency and severity of coronavirus disease 2019 disease in active tuberculosis patients.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"23 1","pages":"58-62"},"PeriodicalIF":0.8,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/22/22/ttj-23-1-58.PMC9450003.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39882000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of Granulomatous Inflammations in Terms of Tuberculosis Diagnosis: A 5-Year Multi-center Laboratory Study. 肉芽肿性炎症在结核病诊断中的研究:一项5年多中心实验室研究。
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2022-01-01 DOI: 10.5152/TurkThoracJ.2022.20314
Derya Öztomurcuk, Özlem Terzi, Canan Demirci, Zeki Kılıçaslan

Objective: Granulomatous inflammation showing "caseification necrosis" is considered pathognomonic for tuberculosis. This study aimed to evaluate patients with granulomatous inflammation and some characteristics to diagnose tuberculosis.

Material and methods: This is a cross-sectional descriptive study. The study includes all pathology laboratories in Samsun between the years 2012 and 2017. Pathology reports that contained the term granulomatous were selected between all patient reports of these laboratories. The patient reports were examined by comparing the dispensary records and the presence of a diagnosis of tuberculosis.

Results: In the 703 pathology reports, it was found that 38% were only granulomatous and 33% were caseous granulomatosis lesions. When the prevalence of tuberculosis according to the presence of microscopic necrosis was observed in granulomatous tissue samples, 85% tuberculosis was found in patients with necrotic granulomatous tissue and 14% tuberculosis was found with non-necrotic lesions. The presence of tuberculosis in necrotic granulomatous tissues was statistically significantly higher (P < .00001).

Conclusion: As a result, when examining a pathology report for the presence of tuberculosis, the existence of a granulomatous reaction should be considered first. Getting stuck on the definition of caseification necrosis will cause the case to be skipped. An indication of necrosis in the pathologic evaluation will guide the diagnosis of tuberculosis.

目的:肉芽肿性炎症表现为“干酪化坏死”被认为是结核病的典型症状。本研究旨在评估肉芽肿性炎症患者的一些特征,以诊断结核病。材料和方法:这是一项横断面描述性研究。该研究包括2012年至2017年三星电子所有病理实验室。病理报告中包含术语肉芽肿是从这些实验室的所有患者报告中选择的。通过比较药房记录和结核病诊断的存在来检查患者报告。结果:703份病理报告中,仅肉芽肿性病变占38%,干酪样肉芽肿性病变占33%。根据肉芽肿组织标本中有无镜下坏死来观察结核的患病率时,坏死性肉芽肿组织中结核的发生率为85%,非坏死性病变中结核的发生率为14%。坏死肉芽肿组织中结核的存在有统计学意义(P < 0.00001)。结论:因此,在检查结核的病理报告时,应首先考虑肉芽肿反应的存在。执着于干酪化坏死的定义会导致病例被跳过。病理评价中的坏死指征将指导肺结核的诊断。
{"title":"Investigation of Granulomatous Inflammations in Terms of Tuberculosis Diagnosis: A 5-Year Multi-center Laboratory Study.","authors":"Derya Öztomurcuk,&nbsp;Özlem Terzi,&nbsp;Canan Demirci,&nbsp;Zeki Kılıçaslan","doi":"10.5152/TurkThoracJ.2022.20314","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2022.20314","url":null,"abstract":"<p><strong>Objective: </strong>Granulomatous inflammation showing \"caseification necrosis\" is considered pathognomonic for tuberculosis. This study aimed to evaluate patients with granulomatous inflammation and some characteristics to diagnose tuberculosis.</p><p><strong>Material and methods: </strong>This is a cross-sectional descriptive study. The study includes all pathology laboratories in Samsun between the years 2012 and 2017. Pathology reports that contained the term granulomatous were selected between all patient reports of these laboratories. The patient reports were examined by comparing the dispensary records and the presence of a diagnosis of tuberculosis.</p><p><strong>Results: </strong>In the 703 pathology reports, it was found that 38% were only granulomatous and 33% were caseous granulomatosis lesions. When the prevalence of tuberculosis according to the presence of microscopic necrosis was observed in granulomatous tissue samples, 85% tuberculosis was found in patients with necrotic granulomatous tissue and 14% tuberculosis was found with non-necrotic lesions. The presence of tuberculosis in necrotic granulomatous tissues was statistically significantly higher (P < .00001).</p><p><strong>Conclusion: </strong>As a result, when examining a pathology report for the presence of tuberculosis, the existence of a granulomatous reaction should be considered first. Getting stuck on the definition of caseification necrosis will cause the case to be skipped. An indication of necrosis in the pathologic evaluation will guide the diagnosis of tuberculosis.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"23 1","pages":"11-16"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3a/3b/ttj-23-1-11.PMC9450166.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39881560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of the Hospitalized Coronavirus Disease 2019 Patients in First 3 Months of the Pandemic. 2019冠状病毒病大流行前3个月住院患者评估
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2022-01-01 DOI: 10.5152/TurkThoracJ.2022.21118
Sevil Alkan, Anıl Akça, Alper Şener, Ebru Doğan, Uğur Gönlügür, Tuncer Şimşek, Şule Özer, Buse Yüksel, Koray Öz, Kemal Kurt

Objective: Data about Turkish coronavirus disease 2019 patients are limited. We evaluated hospitalized coronavirus disease 2019 patients who were followed up in the first 3 months of the pandemic.

Material and methods: This retrospective, single-center, observational study included 415 confirmed hospitalized coronavirus disease 2019 patients. The patients were divided into groups, namely, mild, moderate, and critically ill patients. Symptoms at the time of admission, clinical, laboratory, and imaging findings were examined.

Results: In our study, 6.74% of coronavirus disease 2019 patients had severe disease, 59.5% were male, and the mortality rate was 11.3%. Diabetes mellitus and chronic obstructive pulmonary disease were more frequently seen in critically ill patient groups and hypertension in moderate patient groups. Anemia and aspartate aminotransferase levels were higher in non-survivors among mild coronavirus disease 2019 patients. In the moderate patients' group, aspartate aminotransferase, lactate dehydrogenase, international normalized ratio, ferritin, and D-dimer levels were higher and lymphocyte, hemoglobin levels were lower; in the critically ill patients' group, platelets were lower and uric acid levels were higher in non-survivor patients.

Conclusion: In mild patients, anemia, lymphopenia, and increased aspartate aminotransferase levels; in moderate patients, leukopenia, anemia, and increased aspartate aminotransferase, lactate dehydrogenase, international normalized ratio, ferritin, and D-dimer levels; in the critically ill patient group, lower platelet and increased uric acid levels should be followed closely as they are mortality predictors.

目的:土耳其2019冠状病毒病患者数据有限。我们评估了在大流行的前3个月接受随访的2019年冠状病毒病住院患者。材料和方法:这项回顾性、单中心、观察性研究纳入了415例确诊的2019冠状病毒病住院患者。将患者分为轻、中、危重三组。检查入院时的症状、临床、实验室和影像学表现。结果:我们的研究中,冠状病毒病2019的重症患者占6.74%,男性占59.5%,死亡率为11.3%。糖尿病和慢性阻塞性肺疾病在危重患者组多见,高血压在中度患者组多见。2019年轻度冠状病毒病患者中,非幸存者的贫血和天冬氨酸转氨酶水平较高。中度患者组天冬氨酸转氨酶、乳酸脱氢酶、国际标准化比值、铁蛋白、d -二聚体水平较高,淋巴细胞、血红蛋白水平较低;在危重患者组中,非幸存者患者的血小板较低,尿酸水平较高。结论:轻症患者有贫血、淋巴细胞减少和天冬氨酸转氨酶升高;中度患者出现白细胞减少、贫血、天冬氨酸转氨酶、乳酸脱氢酶、国际标准化比值、铁蛋白和d -二聚体水平升高;在危重病人组,血小板降低和尿酸水平升高应密切关注,因为它们是死亡率的预测因子。
{"title":"Evaluation of the Hospitalized Coronavirus Disease 2019 Patients in First 3 Months of the Pandemic.","authors":"Sevil Alkan,&nbsp;Anıl Akça,&nbsp;Alper Şener,&nbsp;Ebru Doğan,&nbsp;Uğur Gönlügür,&nbsp;Tuncer Şimşek,&nbsp;Şule Özer,&nbsp;Buse Yüksel,&nbsp;Koray Öz,&nbsp;Kemal Kurt","doi":"10.5152/TurkThoracJ.2022.21118","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2022.21118","url":null,"abstract":"<p><strong>Objective: </strong>Data about Turkish coronavirus disease 2019 patients are limited. We evaluated hospitalized coronavirus disease 2019 patients who were followed up in the first 3 months of the pandemic.</p><p><strong>Material and methods: </strong>This retrospective, single-center, observational study included 415 confirmed hospitalized coronavirus disease 2019 patients. The patients were divided into groups, namely, mild, moderate, and critically ill patients. Symptoms at the time of admission, clinical, laboratory, and imaging findings were examined.</p><p><strong>Results: </strong>In our study, 6.74% of coronavirus disease 2019 patients had severe disease, 59.5% were male, and the mortality rate was 11.3%. Diabetes mellitus and chronic obstructive pulmonary disease were more frequently seen in critically ill patient groups and hypertension in moderate patient groups. Anemia and aspartate aminotransferase levels were higher in non-survivors among mild coronavirus disease 2019 patients. In the moderate patients' group, aspartate aminotransferase, lactate dehydrogenase, international normalized ratio, ferritin, and D-dimer levels were higher and lymphocyte, hemoglobin levels were lower; in the critically ill patients' group, platelets were lower and uric acid levels were higher in non-survivor patients.</p><p><strong>Conclusion: </strong>In mild patients, anemia, lymphopenia, and increased aspartate aminotransferase levels; in moderate patients, leukopenia, anemia, and increased aspartate aminotransferase, lactate dehydrogenase, international normalized ratio, ferritin, and D-dimer levels; in the critically ill patient group, lower platelet and increased uric acid levels should be followed closely as they are mortality predictors.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"23 1","pages":"52-57"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/31/43/ttj-23-1-52.PMC9449984.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39881999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronavirus Disease 2019 in Patients with Asthma: Case Study from a Tertiary Center Regarding Their Phenotypes and Their Adherence to Asthma Treatment by Telemedicine. 2019冠状病毒病哮喘患者:来自三级中心的病例研究,关于他们的表型和他们对远程医疗哮喘治疗的依从性。
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2022-01-01 DOI: 10.5152/TurkThoracJ.2021.21097
Buket Çalışkaner Öztürk, Nejdiye Güngördü Mazıcan, Elif Buse Çalışkan, Ali Ata Tuz, Bilun Gemicioğlu

Objective: The aim of this study was to determine the prevalence and the characteristics of coronavirus disease 2019 (COVID-19) in a tertiary outpatient clinic of asthma patients, find the predisposing asthma phenotype to COVID-19, and to see their adherence to asthma treatment.

Material and methods: A retrospective, cross-sectional, real life study was conducted via phone interviews with the patients being followed in the asthma outpatient clinic. From the files of the patient information was obtained about their demographics, asthma phenotype, co-morbidity, prick tests, spirometry test results and their medications at the last visit before the COVID-19 pandemic. Information's about asthma exacerbations, ACT, asthma treatment adherence and history of COVID-19 were obtained via telephone interviews.

Results: Of the 573 patients with asthma, 13 (2.26%) had COVID-19 history. The mean age of patients with asthma and COVID-19 was 51.84±14.92 year. Two patients were on mepolizumab and one was on omalizumab treatment. Mean ACT was 19.84±2.73. Lack of adherence was reported in 8% of all patients with asthma compared to 23% in the patients who had COVID-19. Asthma exacerbation was seen during the course of SARS-CoV2 infection in 3 of 13 patients with asthma. Asthma exacerbations were reported during the period of one month following COVID-19 in 2 patients.

Conclusion: The most common asthma phenotype in the cases of COVID-19 was obese phenotype. Rates of using biological agents and non-adherence to the treatment were found to be higher. Asthma exacerbation may be seen during course of COVID-19 albeit being less common.

目的:了解某三级门诊哮喘患者2019冠状病毒病(COVID-19)的患病率及特征,发现易患COVID-19的哮喘表型,并观察其对哮喘治疗的依从性。材料和方法:通过电话访谈对哮喘门诊患者进行回顾性、横断面、真实生活研究。从患者档案中获取患者在COVID-19大流行前最后一次就诊时的人口统计学信息、哮喘表型、合并症、点刺试验、肺活量测定结果和用药信息。通过电话访问获得哮喘加重、ACT、哮喘治疗依从性和COVID-19病史等信息。结果:573例哮喘患者中有新冠肺炎病史13例(2.26%)。哮喘合并新冠肺炎患者的平均年龄为51.84±14.92岁。两名患者接受美波珠单抗治疗,一名接受奥玛珠单抗治疗。平均ACT为19.84±2.73。在所有哮喘患者中,有8%的人缺乏依从性,而在COVID-19患者中,这一比例为23%。13例哮喘患者中有3例在SARS-CoV2感染过程中出现哮喘加重。2例患者在COVID-19感染后1个月内出现哮喘加重。结论:新冠肺炎患者中最常见的哮喘表型为肥胖表型。使用生物制剂和不坚持治疗的比率较高。在COVID-19期间可能会出现哮喘恶化,尽管不太常见。
{"title":"Coronavirus Disease 2019 in Patients with Asthma: Case Study from a Tertiary Center Regarding Their Phenotypes and Their Adherence to Asthma Treatment by Telemedicine.","authors":"Buket Çalışkaner Öztürk,&nbsp;Nejdiye Güngördü Mazıcan,&nbsp;Elif Buse Çalışkan,&nbsp;Ali Ata Tuz,&nbsp;Bilun Gemicioğlu","doi":"10.5152/TurkThoracJ.2021.21097","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2021.21097","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to determine the prevalence and the characteristics of coronavirus disease 2019 (COVID-19) in a tertiary outpatient clinic of asthma patients, find the predisposing asthma phenotype to COVID-19, and to see their adherence to asthma treatment.</p><p><strong>Material and methods: </strong>A retrospective, cross-sectional, real life study was conducted via phone interviews with the patients being followed in the asthma outpatient clinic. From the files of the patient information was obtained about their demographics, asthma phenotype, co-morbidity, prick tests, spirometry test results and their medications at the last visit before the COVID-19 pandemic. Information's about asthma exacerbations, ACT, asthma treatment adherence and history of COVID-19 were obtained via telephone interviews.</p><p><strong>Results: </strong>Of the 573 patients with asthma, 13 (2.26%) had COVID-19 history. The mean age of patients with asthma and COVID-19 was 51.84±14.92 year. Two patients were on mepolizumab and one was on omalizumab treatment. Mean ACT was 19.84±2.73. Lack of adherence was reported in 8% of all patients with asthma compared to 23% in the patients who had COVID-19. Asthma exacerbation was seen during the course of SARS-CoV2 infection in 3 of 13 patients with asthma. Asthma exacerbations were reported during the period of one month following COVID-19 in 2 patients.</p><p><strong>Conclusion: </strong>The most common asthma phenotype in the cases of COVID-19 was obese phenotype. Rates of using biological agents and non-adherence to the treatment were found to be higher. Asthma exacerbation may be seen during course of COVID-19 albeit being less common.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"23 1","pages":"25-31"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/87/00/ttj-23-1-25.PMC9450126.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39881562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PDL-1 Expression and Survival in Metastatic Non-small Cell Lung Cancer Patients Who Received Chemotherapy as First-Line Treatment. 接受化疗作为一线治疗的转移性非小细胞肺癌患者的PDL-1表达和生存率。
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2022-01-01 DOI: 10.5152/TurkThoracJ.2021.21151
Pınar Gursoy, Burcu Çakar, Damla Gunenc, Deniz Nart, Akın Çınkooğlu, Nuran Katgı

Objective: To show the effect of programmed cell death protein-1ligand (PDL-1) level on survival times in patients with metastatic non-small cell lung cancer (mNSCLC) receiving chemotherapy, to determine the relationship between PDL-1 level, neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR).

Material and methods: The data of 158 patients who received chemotherapy for mNSCLC were evaluated retrospectively. Clinical and demographic data, PDL-1 expression levels and follow-up periods of the patients were recorded. The patients were divided into 2 groups according to PDL-1 levels.

Results: In all patients, progression free survival (PFS) was 5.6 months and overall survival (OS) was 18.8 months. Patients with low PDL-1 had a longer PFS than patients with high PDL-1 (p:0.038). In the gemcitabine and taxane groups, patients with low PDL-1 had a longer PFS than patients with high PDL-1 (p:0.047). There was a significant correlation between NLR and PDL-1 levels. In the groups with high PDL-1, patients with low NLR levels had higher OS than patients with high NLR level (p:0.043). Also, there was a significant difference between the OS patients with low and high PLR levels (p:0.520).

Conclusion: In patients with mNSCLC whose PDL-1 levels and NLR levels are low, immunogenic chemotherapies such as gemcitabine and taxane can be tried as an alternative treatment.

目的:探讨程序性细胞死亡蛋白-1配体(PDL-1)水平对转移性非小细胞肺癌(mNSCLC)化疗患者生存时间的影响,探讨PDL-1水平与中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)的关系。材料与方法:回顾性分析158例小细胞肺癌化疗患者的资料。记录患者的临床及人口学资料、PDL-1表达水平及随访时间。根据PDL-1水平将患者分为两组。结果:所有患者无进展生存期(PFS)为5.6个月,总生存期(OS)为18.8个月。低PDL-1患者的PFS较高PDL-1患者长(p:0.038)。在吉西他滨和紫杉烷组中,低PDL-1的患者比高PDL-1的患者的PFS更长(p:0.047)。NLR与PDL-1水平有显著相关性。在高PDL-1组中,低NLR患者的OS高于高NLR患者(p:0.043)。此外,低PLR水平和高PLR水平的OS患者之间存在显著差异(p:0.520)。结论:对于PDL-1水平和NLR水平较低的小细胞肺癌患者,可尝试免疫原性化疗如吉西他滨和紫杉烷作为替代治疗。
{"title":"PDL-1 Expression and Survival in Metastatic Non-small Cell Lung Cancer Patients Who Received Chemotherapy as First-Line Treatment.","authors":"Pınar Gursoy,&nbsp;Burcu Çakar,&nbsp;Damla Gunenc,&nbsp;Deniz Nart,&nbsp;Akın Çınkooğlu,&nbsp;Nuran Katgı","doi":"10.5152/TurkThoracJ.2021.21151","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2021.21151","url":null,"abstract":"<p><strong>Objective: </strong>To show the effect of programmed cell death protein-1ligand (PDL-1) level on survival times in patients with metastatic non-small cell lung cancer (mNSCLC) receiving chemotherapy, to determine the relationship between PDL-1 level, neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR).</p><p><strong>Material and methods: </strong>The data of 158 patients who received chemotherapy for mNSCLC were evaluated retrospectively. Clinical and demographic data, PDL-1 expression levels and follow-up periods of the patients were recorded. The patients were divided into 2 groups according to PDL-1 levels.</p><p><strong>Results: </strong>In all patients, progression free survival (PFS) was 5.6 months and overall survival (OS) was 18.8 months. Patients with low PDL-1 had a longer PFS than patients with high PDL-1 (p:0.038). In the gemcitabine and taxane groups, patients with low PDL-1 had a longer PFS than patients with high PDL-1 (p:0.047). There was a significant correlation between NLR and PDL-1 levels. In the groups with high PDL-1, patients with low NLR levels had higher OS than patients with high NLR level (p:0.043). Also, there was a significant difference between the OS patients with low and high PLR levels (p:0.520).</p><p><strong>Conclusion: </strong>In patients with mNSCLC whose PDL-1 levels and NLR levels are low, immunogenic chemotherapies such as gemcitabine and taxane can be tried as an alternative treatment.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"23 1","pages":"45-51"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f7/7d/ttj-23-1-45.PMC9450090.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39881998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COP26 and Health: Some Progress, But Too Slow and Not Enough. COP26与健康:取得了一些进展,但太慢而且不够。
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2022-01-01 DOI: 10.5152/TurkThoracJ.2022.21221
Laurie Laybourn-Langton, Richard Smith
{"title":"COP26 and Health: Some Progress, But Too Slow and Not Enough.","authors":"Laurie Laybourn-Langton,&nbsp;Richard Smith","doi":"10.5152/TurkThoracJ.2022.21221","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2022.21221","url":null,"abstract":"","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"23 1","pages":"4-5"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5f/3c/ttj-23-1-4.PMC9450140.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39881558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Persistent Post-COVID Symptoms and the Related Factors. 持续的covid后症状及其相关因素。
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2022-01-01 DOI: 10.5152/TurkThoracJ.2022.21112
Barış Çil, Mehmet Kabak

Objective: The recently emerged coronavirus 2019 disease is an infectious disease that predominantly affects the respiratory system. In this study, we aimed to evaluate the persistent post-COVID symptoms and the related factors.

Material and methods: This study was conducted on 396 post-COVID patients. The demographic (age, gender, body mass index, smoking, location and duration of treatment, and date of post-COVID follow-up visit) and clinical (symptoms during and after the infection, comorbidities) data were evaluated by interview and a questionnaire.

Results: The mean age of the patients was 50.25 years (min-max: 19-85). There were equal numbers of males (n = 198) and females (n = 198) in the study. The mean body mass index was 27.94 (min-max: 17.90-44.92). The majority of patients (n = 222, 56.1%) had been treated at home, while the rates of patients admitted to ward and intensive care unit were 37.1% (n = 147) and 6.8% (n = 27), respectively. The number of patients with at least 1 persistent symptom during post-COVID follow-up visit was 348 (87.9%). The symptoms during the infection included fatigue (n = 339, 85.6%), cough (n = 373, 68.9%), joint pain (n = 267, 67.4%), appetite loss (n = 234, 59.1%), dyspnea (n = 231, 58.3%), while the persistent post-COVID symptoms were fatigue (n = 222, 56.1%), cough (n = 174, 43.9%), dyspnea (n = 171, 43.2%), and chest pain (n = 171, 43.2%). No significant relationships between post-COVID symptoms and age, body mass index, comorbidity, duration from diagnosis to a follow-up visit, and COVID-19 pneumonia during the infection were found, while a statistically significant relationship regarding gender was found.

Conclusion: There is still a lack of knowledge about the long-term consequences of coronavirus 2019 disease. Moreover, no standardized method exists for categorizing patients into post-COVID controls.

目的:新型冠状病毒2019是一种主要影响呼吸系统的传染病。在本研究中,我们旨在评估持续的covid后症状及其相关因素。材料和方法:本研究对396例新冠肺炎后患者进行研究。通过访谈和问卷调查评估人口统计学(年龄、性别、体重指数、吸烟、治疗地点和持续时间以及covid后随访日期)和临床(感染期间和感染后的症状、合并症)数据。结果:患者平均年龄50.25岁(最小-最大19-85岁)。研究中男性(n = 198)和女性(n = 198)人数相等。平均体重指数为27.94(最小-最大值为17.90-44.92)。大多数患者(n = 222, 56.1%)在家中接受治疗,住院率为37.1% (n = 147),重症监护病房住院率为6.8% (n = 27)。随访期间出现至少1种持续症状的患者348例(87.9%)。感染期间的症状包括疲劳(n = 339, 85.6%)、咳嗽(n = 373,68.9%)、关节疼痛(n = 267, 67.4%)、食欲不振(n = 234, 59.1%)、呼吸困难(n = 231, 58.3%),持续出现的症状为疲劳(n = 222, 56.1%)、咳嗽(n = 174, 43.9%)、呼吸困难(n = 171, 43.2%)和胸痛(n = 171, 43.2%)。COVID-19后症状与年龄、体重指数、合并症、诊断至随访时间、感染期间COVID-19肺炎无显著相关性,与性别有显著相关性。结论:人们对2019冠状病毒病的长期后果仍然缺乏了解。此外,没有标准化的方法将患者分类为covid后对照。
{"title":"Persistent Post-COVID Symptoms and the Related Factors.","authors":"Barış Çil,&nbsp;Mehmet Kabak","doi":"10.5152/TurkThoracJ.2022.21112","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2022.21112","url":null,"abstract":"<p><strong>Objective: </strong>The recently emerged coronavirus 2019 disease is an infectious disease that predominantly affects the respiratory system. In this study, we aimed to evaluate the persistent post-COVID symptoms and the related factors.</p><p><strong>Material and methods: </strong>This study was conducted on 396 post-COVID patients. The demographic (age, gender, body mass index, smoking, location and duration of treatment, and date of post-COVID follow-up visit) and clinical (symptoms during and after the infection, comorbidities) data were evaluated by interview and a questionnaire.</p><p><strong>Results: </strong>The mean age of the patients was 50.25 years (min-max: 19-85). There were equal numbers of males (n = 198) and females (n = 198) in the study. The mean body mass index was 27.94 (min-max: 17.90-44.92). The majority of patients (n = 222, 56.1%) had been treated at home, while the rates of patients admitted to ward and intensive care unit were 37.1% (n = 147) and 6.8% (n = 27), respectively. The number of patients with at least 1 persistent symptom during post-COVID follow-up visit was 348 (87.9%). The symptoms during the infection included fatigue (n = 339, 85.6%), cough (n = 373, 68.9%), joint pain (n = 267, 67.4%), appetite loss (n = 234, 59.1%), dyspnea (n = 231, 58.3%), while the persistent post-COVID symptoms were fatigue (n = 222, 56.1%), cough (n = 174, 43.9%), dyspnea (n = 171, 43.2%), and chest pain (n = 171, 43.2%). No significant relationships between post-COVID symptoms and age, body mass index, comorbidity, duration from diagnosis to a follow-up visit, and COVID-19 pneumonia during the infection were found, while a statistically significant relationship regarding gender was found.</p><p><strong>Conclusion: </strong>There is still a lack of knowledge about the long-term consequences of coronavirus 2019 disease. Moreover, no standardized method exists for categorizing patients into post-COVID controls.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"23 1","pages":"6-10"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4e/09/ttj-23-1-6.PMC9449913.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39881559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
COVID-19 Outbreak in İstanbul. 伊斯坦布尔爆发的 COVID-19。
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2022-01-01 DOI: 10.5152/TurkThoracJ.2022.21088
Nilüfer Aykaç, Osman Elbek

Objective: The COVID-19 pandemic has demonstrated that the social determinants of health play a fundamental role in the course of the pandemic. This article aims to reveal the class dynamics of the COVID-19 epidemic in İstanbul, Turkey.

Material and methods: Spatial analysis and geographic information system data provided by İstanbul Metropolitan Municipality for March and April 2020 were used. Public transport mobility and turnstile data were analyzed. The data obtained were collated into thematic maps.

Results: Between March 16 and 24, 2020, the use of public transportation declined with the tightening of movement restrictions. However, despite the restrictions, an increase in transportation density was observed between 6 and 9 am and between 5 and 7 pm. Although the overall mobility toward outside the city has fallen due to travel restrictions, it has been observed that exit mobility continued between Gebze and Kocaeli, both industrial centers where blue-collar jobs dominate. Most of the mobility in the city is observed in Avcılar, Bahçelievler, Esenyurt, and Küçükçekmece, which are mostly blue-collar residential districts. On the Asian side, activity was observed in Kurtköy, Pendik, Samandıra, Ümraniye, and Tuzla, areas where blue-collar workers predominantly reside. From March 25 to April 7, 2020, it was determined that the most intense activity areas of the blue-collar workers were Avcılar, Bahçelievler, Bağcılar, Çekmeköy, Esenyurt, Küçükçekmece, Ümraniye, and D-100 highway line.

Conclusion: The density in the use of public transportation rose during the hours corresponding to the working hours of the workers who had to continue working despite the pandemic. In addition, the physical movement of blue-collar workers continued despite the travel restrictions imposed along the city borders where they worked and resided. Our data point to the importance of social protection measures for workers in general, and blue-collar workers in particular, for the management of the pandemic.

目的:2019冠状病毒病大流行表明,健康的社会决定因素在大流行过程中发挥着根本作用。本文旨在揭示新冠肺炎疫情在土耳其İstanbul的阶级动态。材料和方法:空间分析和2020年3月和4月由İstanbul大都会市提供的地理信息系统数据。对公共交通机动性和十字转门数据进行分析。获得的数据被整理成专题地图。结果:2020年3月16日至24日,随着出行限制的收紧,公共交通的使用量有所下降。然而,尽管有这些限制,在上午6点至9点和下午5点至7点之间观察到交通密度增加。尽管由于出行限制,向城外的总体流动性有所下降,但据观察,格布泽和科卡埃利之间的出口流动性仍在继续,这两个工业中心都以蓝领工作为主。城市的流动性主要集中在Avcılar、bahelievler、Esenyurt和k ekmece,这些地区主要是蓝领住宅区。在亚洲方面,在蓝领工人主要居住的Kurtköy、Pendik、Samandıra、Ümraniye和图兹拉地区观察到活动。从2020年3月25日至4月7日,确定蓝领工人活动最密集的区域为Avcılar、bahelievler、Bağcılar、Çekmeköy、Esenyurt、k ekmece、Ümraniye和D-100高速公路线。结论:在疫情下仍需继续工作的人员的工作时间内,公共交通工具的使用密度上升。此外,尽管蓝领工人工作和居住的城市边界沿线实行旅行限制,但他们的实际行动仍在继续。我们的数据表明,对一般工人,特别是蓝领工人采取社会保护措施,对于控制疫情的重要性。
{"title":"COVID-19 Outbreak in İstanbul.","authors":"Nilüfer Aykaç,&nbsp;Osman Elbek","doi":"10.5152/TurkThoracJ.2022.21088","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2022.21088","url":null,"abstract":"<p><strong>Objective: </strong>The COVID-19 pandemic has demonstrated that the social determinants of health play a fundamental role in the course of the pandemic. This article aims to reveal the class dynamics of the COVID-19 epidemic in İstanbul, Turkey.</p><p><strong>Material and methods: </strong>Spatial analysis and geographic information system data provided by İstanbul Metropolitan Municipality for March and April 2020 were used. Public transport mobility and turnstile data were analyzed. The data obtained were collated into thematic maps.</p><p><strong>Results: </strong>Between March 16 and 24, 2020, the use of public transportation declined with the tightening of movement restrictions. However, despite the restrictions, an increase in transportation density was observed between 6 and 9 am and between 5 and 7 pm. Although the overall mobility toward outside the city has fallen due to travel restrictions, it has been observed that exit mobility continued between Gebze and Kocaeli, both industrial centers where blue-collar jobs dominate. Most of the mobility in the city is observed in Avcılar, Bahçelievler, Esenyurt, and Küçükçekmece, which are mostly blue-collar residential districts. On the Asian side, activity was observed in Kurtköy, Pendik, Samandıra, Ümraniye, and Tuzla, areas where blue-collar workers predominantly reside. From March 25 to April 7, 2020, it was determined that the most intense activity areas of the blue-collar workers were Avcılar, Bahçelievler, Bağcılar, Çekmeköy, Esenyurt, Küçükçekmece, Ümraniye, and D-100 highway line.</p><p><strong>Conclusion: </strong>The density in the use of public transportation rose during the hours corresponding to the working hours of the workers who had to continue working despite the pandemic. In addition, the physical movement of blue-collar workers continued despite the travel restrictions imposed along the city borders where they worked and resided. Our data point to the importance of social protection measures for workers in general, and blue-collar workers in particular, for the management of the pandemic.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"23 1","pages":"63-69"},"PeriodicalIF":0.9,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/41/ae/ttj-23-1-63.PMC9450054.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39882001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Awareness and Knowledge of COVID-19 Among Health Care Workers in Early Phase of COVID-19 Pandemic. COVID-19 大流行初期医护人员对 COVID-19 的认识和了解。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2022-01-01 DOI: 10.5152/TurkThoracJ.2022.21170
Serap Argun Barış, Emine Ünal Evren, Hakan Evren, Ece Şahinoğlu, Gözde Selvi, Haşim Boyacı, İlknur Başyiğit, Füsun Yıldız

Objective: The study aims to evaluate the awareness and knowledge of COVID-19 among healthcare workers.

Material and methods: A questionnaire was applied to healthcare workers working at Kocaeli University Faculty of Medicine and University of Kyrenia, Dr. Suat Günsel Hospital, to evaluate the coronavirus disease 2019 awareness and level of knowledge.

Results: A total of 598 healthcare workers participated in the study. Two-thirds of the respondents were from Turkey, while one-third were from the Turkish Republic of Northern Cyprus. The general symptoms of coronavirus disease 2019 were well known in the general population. Awareness of most symptoms was significantly lower in the Turkish Republic of Northern Cyprus group. It was well known that coronavirus disease 2019 can be asymptomatic in some patients and it can be contagious. The necessity of wearing surgical masks on sick individuals was less known in the Turkish Republic of Northern Cyprus group (96.6% vs 61.6%; P = .000). While handwashing was found similar in both groups for protection from coronavirus disease 2019 transmission, social distance and mask recommendations were lower in the Turkish Republic of Northern Cyprus group (P < .05). The concern about transmitting the virus to themselves and their relatives was more significant in the Turkish Republic of Northern Cyprus group than the Turkey group (84.4% vs 96.5%; P = .000). And 92.2% of the healthcare workers thought they should stay in an alternative place instead of their homes.

Conclusion: The awareness and knowledge level of coronavirus disease 2019 is higher in Turkey than in Turkish Republic of Northern Cyprus related to the increased number of coronavirus disease 2019 cases in Turkey. Continuous education programs can contribute to improving the level of knowledge and reducing anxiety.

研究目的研究旨在评估医护人员对COVID-19的认识和知识:对在科贾埃利大学医学院和凯里尼亚大学苏亚特-贡塞尔博士医院工作的医护人员进行问卷调查,以评估他们对 2019 年冠状病毒病的认识和知识水平:共有 598 名医护人员参与了研究。三分之二的受访者来自土耳其,三分之一来自北塞浦路斯土耳其共和国。2019年冠状病毒疾病的一般症状在普通人群中广为人知。北塞浦路斯土耳其共和国组对大多数症状的了解程度明显较低。众所周知,2019 年冠状病毒病在某些患者身上可能没有症状,而且可能具有传染性。北塞浦路斯土耳其共和国组对病人佩戴外科口罩的必要性了解较少(96.6% 对 61.6%;P = 0.000)。虽然两组在预防 2019 年冠状病毒疾病传播方面的洗手情况相似,但北塞浦路斯土耳其共和国组的社交距离和口罩推荐率较低(P < .05)。北塞浦路斯土耳其共和国组比土耳其组更担心将病毒传染给自己和亲属(84.4% 对 96.5%;P = .000)。92.2%的医护人员认为他们应该呆在其他地方而不是家里:土耳其对2019年冠状病毒病的认识和知识水平高于北塞浦路斯土耳其共和国,这与土耳其2019年冠状病毒病病例数量增加有关。持续教育计划有助于提高知识水平和减少焦虑。
{"title":"Awareness and Knowledge of COVID-19 Among Health Care Workers in Early Phase of COVID-19 Pandemic.","authors":"Serap Argun Barış, Emine Ünal Evren, Hakan Evren, Ece Şahinoğlu, Gözde Selvi, Haşim Boyacı, İlknur Başyiğit, Füsun Yıldız","doi":"10.5152/TurkThoracJ.2022.21170","DOIUrl":"10.5152/TurkThoracJ.2022.21170","url":null,"abstract":"<p><strong>Objective: </strong>The study aims to evaluate the awareness and knowledge of COVID-19 among healthcare workers.</p><p><strong>Material and methods: </strong>A questionnaire was applied to healthcare workers working at Kocaeli University Faculty of Medicine and University of Kyrenia, Dr. Suat Günsel Hospital, to evaluate the coronavirus disease 2019 awareness and level of knowledge.</p><p><strong>Results: </strong>A total of 598 healthcare workers participated in the study. Two-thirds of the respondents were from Turkey, while one-third were from the Turkish Republic of Northern Cyprus. The general symptoms of coronavirus disease 2019 were well known in the general population. Awareness of most symptoms was significantly lower in the Turkish Republic of Northern Cyprus group. It was well known that coronavirus disease 2019 can be asymptomatic in some patients and it can be contagious. The necessity of wearing surgical masks on sick individuals was less known in the Turkish Republic of Northern Cyprus group (96.6% vs 61.6%; P = .000). While handwashing was found similar in both groups for protection from coronavirus disease 2019 transmission, social distance and mask recommendations were lower in the Turkish Republic of Northern Cyprus group (P < .05). The concern about transmitting the virus to themselves and their relatives was more significant in the Turkish Republic of Northern Cyprus group than the Turkey group (84.4% vs 96.5%; P = .000). And 92.2% of the healthcare workers thought they should stay in an alternative place instead of their homes.</p><p><strong>Conclusion: </strong>The awareness and knowledge level of coronavirus disease 2019 is higher in Turkey than in Turkish Republic of Northern Cyprus related to the increased number of coronavirus disease 2019 cases in Turkey. Continuous education programs can contribute to improving the level of knowledge and reducing anxiety.</p>","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"23 1","pages":"38-44"},"PeriodicalIF":0.8,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8b/7a/ttj-23-1-38.PMC9450079.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39881997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum. 勘误表。
IF 0.9 Q4 RESPIRATORY SYSTEM Pub Date : 2021-11-01 DOI: 10.5152/TurkThoracJ.2020.210001
{"title":"Erratum.","authors":"","doi":"10.5152/TurkThoracJ.2020.210001","DOIUrl":"https://doi.org/10.5152/TurkThoracJ.2020.210001","url":null,"abstract":"","PeriodicalId":37452,"journal":{"name":"Turkish Thoracic Journal","volume":"22 6","pages":"514"},"PeriodicalIF":0.9,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975351/pdf/ttj-22-6-514.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39583524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Turkish Thoracic Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1